This online on-demand seminar gives a comprehensive understanding of the hospital reimbursement landscape for medical devices in the Netherlands. Additional modules cover reimbursement of IVD tests and medical aids
Available as a pre-recorded webinar or full presentation in Acrobat PDF
The Netherlands is a very attractive market for medical technologies. Tariffs for hospital care are among the highest in Europe.
All hospital procedures are reimbursed via the DRG system. Majority of the DRGs do not have national tariff and negotiated between individual hospitals and insurance companies. There is no add-on reimbursement for medical devices, but it exists for some services that require additional resources. Another interesting aspect of the system is that one DRG covers the period of care of four months for one disease, which creates a form of a bundled payment for integrated care.
Market access is rather complicated in the Netherlands. It has two aspects: reimbursement (creation of procedure code and allocation to DRG by the Dutch Healthcare Authority) and funding (inclusion into Basic Health Insurance by the Dutch Healthcare Institute). Inclusion in BHI is based on the review of clinical evidence via national health technology assessment.
We built this seminar based on experience from dozens of market access projects in the Netherlands, to help develop a better understanding of the market access landscape in the country and to inform better business decisions on whether to go to this market or not and if yes, how to approach it.
Key stakeholders are reviewed, including payers, policy-makers, manager of DRG system and organizations responsible for innovation payment scheme
Money flow and distribution of funds, compartments of Dutch healthcare system, an overview of the hospital payment system (DRG system), the process for inclusion of novel procedures in the DRG system
Coverage of services within the Basic Health Insurance, process of inclusion of novel procedures into the system
Small scale experiment and subsidy for promising care schemes, pilots by individual insurance companies
A separate comprehensive overview of the reimbursement system for IVD tests in the Netherlands
A separate comprehensive overview of the reimbursement system for medical aids in the Netherlands
Some topics are not specifically covered in this seminar: reimbursement model in out-patient settings, funding of capital equipment.
The introductory presentation also does not include details of reimbursement application processes (for example application form, requirements, details of the process for the creation of procedure code or DRG change).
Topics that are not covered in this seminar will be included in future courses. You can subscribe to our newsletter and inform us about your particular interests at the main page of the Market Access Academy.
One option is to watch the seminar, which is provided as a pre-recorded webinar. The duration of the webinar is 28 minutes. Webinar is available for 6 months
You can also access just the educational material - the full presentation of the seminar in Acrobat PDF
This 3-minute extract presents overview of the Dutch diagnosis-related group (DBC) system
January 2022: Update of the overview of the Dutch hospital reimbursement system (slides with an overview of OZPs were updated, description of the Optional Services was updated, a new slide on the aspects of market access for medical technologies was added)
November 2020: Update of the overview of the Dutch hospital reimbursement system (slide with the list of Healthcare sectors within the Dutch healthcare system was added, a description of Payment model in Dutch health care system was updated, added the information on Other care products (OZPs), slide for Optional Service for primary diagnostics was added, slide with an overview of the pathway for implementation of novel procedure code was added, developed table with an Overview of reimbursement/funding pathways)